Sclerostin is expressed in the atherosclerotic plaques of patients who undergoing carotid endarterectomy
Diabetes/Metabolism Research and Reviews2018Vol. 35(1), pp. e3069–e3069
Citations Over TimeTop 22% of 2018 papers
Gaetano Leto, Luca D’Onofrio, Federica Lucantoni, Simona Zampetti, Giuseppe Campagna, Chiara Foffi, Chiara Moretti, Angela Carlone, Andrea Palermo, Martina Leopizzi, Natale Porta, Marco Massucci, Andrea Lenzi, Giovanni Bertoletti, Carlo Della Rocca, Raffaella Buzzetti
Abstract
We have demonstrated, for the first time, the expression of SC in VSMCs of atherosclerotic plaques, suggesting a potential role for this protein in the development of atherosclerosis. Further studies are needed to understand if the role played by SC is detrimental or protective in the atherosclerotic disease process.
Related Papers
- → Novel actions of sclerostin on bone(2018)100 cited
- → Sclerostin measurement in human disease: Validity and current limitations(2016)24 cited
- → Sclerostin Loop3 Participates in Whole-body Lipid and Glucose Metabolism Impairment Effects of Sclerostin(2023)1 cited
- → Serum Sclerostin as Biomarker in Osteogenesis Imperfecta(2015)1 cited
- → Serum Sclerostin as Biomarker in Osteogenesis Imperfecta(2017)1 cited